SRRA - Sierra Oncology Inc
Close
54.99
0.020 0.036%
Share volume: 0
Last Updated: Thu 30 Jun 2022 10:00:00 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$54.97
0.02
0.04%
Summary score
45%
Profitability
50%
Dept financing
5%
Liquidity
50%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-16.41%
Return on assets
-12.22%
Return on sales
0%
Return on invested capital
200.62%
Total debt ratio
11.15%
Debt ratio change over timeo
-0.94%
Current Ratio
14.42%
Quick Ratio
0%
Cash Position Ratio
14.44%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-28.91%
Return on assets
-14.93%
Return on sales
0%
Return on invested capital
254.55%
Total debt ratio
18.56%
Debt ratio change over timeo
-0.89%
Current Ratio
10.81%
Quick Ratio
0%
Cash Position Ratio
10.61%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-14.11%
Return on assets
-13.07%
Return on sales
0%
Return on invested capital
213.43%
Total debt ratio
7.34%
Debt ratio change over time
-0.99%
Current Ratio
13.88%
Quick Ratio
0%
Cash Position Ratio
13.72%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-110.32%
Return on assets
-107.15%
Return on sales
0%
Return on invested capital
41.95%
Total debt ratio
-93.61%
Debt ratio change over time
-0.94%
Current Ratio
8.31%
Quick Ratio
0%
Cash Position Ratio
8.3%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SRRA | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -16.41% | 0% | 0% | 29.06% |
| Return on assets | -12.22% | 0% | 0% | -9.75% |
| Return on sales | 0% | 0% | 0% | -1469.44% |
| Return on invested capital | 200.62% | 0% | 0% | 47.78% |
| Profitability | 50% | 0% | 25% | 31% |
| Total debt ratio | 11.15% | 0% | 0% | 183.15% |
| Debt ratio change over time | -0.94% | 0% | 0% | 19.02% |
| Dept financing | 2% | 0% | 0% | 50% |
| Current Ratio | 10.81% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 10.61% | 0% | 0% | 5.68% |
| Liquididy | 50% | 0% | 0% | 39% |
| Short-term ratios | SRRA | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -28.91% | 0% | 0% | -16.12% |
| Return on assets | -14.93% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | 254.55% | 0% | 0% | 96.56% |
| Profitability | 50% | 0% | 50% | 9% |
| Total debt ratio | 18.56% | 0% | 0% | 79.61% |
| Debt ratio change over time | -0.89% | 0% | 0% | 0.09% |
| Dept financing | 6% | 0% | 0% | 50% |
| Current Ratio | 10.81% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 10.61% | 0% | 0% | 5.68% |
| Liquididy | 50% | 0% | 0% | 52% |